United States
Premiumsupplier
Carisbamate-d4 CAS NO.1292841-50-9
- Min.Order: 1 Gram
- Payment Terms: L/C
- Product Details
Keywords
- (1S)-1-(2-Chlorophenyl-d4)-1,2-ethanediol 2-Carbamate
- JNJ 10234094-d4
- RWJ 333369-d4
Quick Details
- ProName: Carisbamate-d4
- CasNo: 1292841-50-9
- Molecular Formula: C9H6ClNO3D4
- Application: labelled Carisbamate; it is being deve...
- DeliveryTime: 7 days
- PackAge: inquiry
- Port: inquiry
- ProductionCapacity: 10 Kilogram/Month
- Purity: 95%
- Transportation: inquiry
- LimitNum: 1 Gram
Superiority
BOC Sciences is committed to supplying cost-effective products and services. We provide Carisbamate-d4. labelled Carisbamate; it is being developed for adjuvant treatment of partial onset epilepsy. Carisbamate produces anticonvulsant effects in primary generalized, complex partial and absence-type seizure models, and exhibits neuroprotective and antiepileptogenic properties in rodent epilepsy models. More information please visit: www.bocsci.com/carisbamate-d4-cas-1292841-50-9-item-468180.html
Details
BOC Sciences is committed to supplying cost-effective products and services. We provide Carisbamate-d4. labelled Carisbamate; it is being developed for adjuvant treatment of partial onset epilepsy. Carisbamate produces anticonvulsant effects in primary generalized, complex partial and absence-type seizure models, and exhibits neuroprotective and antiepileptogenic properties in rodent epilepsy models. More information please visit: www.bocsci.com/carisbamate-d4-cas-1292841-50-9-item-468180.html